Sec Form 4 Filing - ROOT HOWARD @ VASCULAR SOLUTIONS INC - 2017-02-17

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person ROOT HOWARD 2. Issuer Name and Ticker or Trading Symbol VASCULAR SOLUTIONS INC [ VASC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) C/O VASCULAR SOLUTIONS, INC., 6464 SYCAMORE COURT NORTH 3. Date of Earliest Transaction (MM/DD/YY) 02/17/2017 (Street) MINNEAPOLIS, MN55369 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 319,772 D Common Stock 02/17/2017 D 319,772 D 0 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to Buy) ( 2 ) ( 3 ) ( 4 ) ( 5 ) 02/17/2017 D 360,000 ( 2 )( 3 )( 4 )( 5 ) 01/27/2022 Common Stock 360,000 ( 2 ) ( 3 ) ( 4 ) ( 5 ) 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other ROOT HOWARD C/O VASCULAR SOLUTIONS, INC. 6464 SYCAMORE COURT NORTH MINNEAPOLIS, MN55369 X Chief Executive Officer Signatures /s/ Howard C. Root 02/22/2017 Signature of Reporting Person Date

Explanation of Responses:

( 1 )In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes. ( 2 )90,000 shares, which vested on January 27, 2014 with an exercise price of $12.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $43.97 per share, or $3,957,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes. ( 3 )90,000 shares, which vested on January 27, 2015 with an exercise price of $13.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $42.97 per share, or $3,867,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes. ( 4 )90,000 shares, which vested on January 27, 2016 with an exercise price of $14.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $41.97 per share, or $3,777,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes. ( 5 )90,000 shares, which vested on January 27, 2017 with an exercise price of $15.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $40.97 per share, or $3,687,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.